Please assess the completion status of the following clinical trial:

Trial Title: BLI800-303: An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Male or female outpatients who are undergoing colonoscopy for a routinely accepted indication.~2. At least 18 years of age~3. Otherwise in good health, as determined by physical exam and medical history~4. If female, and of child-bearing potential, is using an acceptable form of birth control~5. Negative urine pregnancy test at screening, if applicable~6. In the Investigator's judgment, subject is mentally competent to provide informed consent to participate in the study~Exclusion Criteria:~1. Subjects with known or suspected ileus, severe ulcerative colitis, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis or megacolon.~2. Subjects who had previous gastrointestinal surgeries.~3. Subjects with known or suspected electrolyte abnormalities such as hypernatremia, hyponatremia, hyperphosphatemia, hypokalemia, hypocalcemia, dehydration, or those secondary to the use of diuretics or angiotensin converting enzyme (ACE) inhibitors.~4. Subjects with clinically significant electrolyte abnormalities based on Visit 1 laboratory results.~5. Subjects with impaired consciousness that predisposes them to pulmonary aspiration.~6. Subjects undergoing colonoscopy for foreign body removal and decompression.~7. Subjects who are pregnant or lactating, or intending to become pregnant during the study.~8. Subjects of childbearing potential who refuse a pregnancy test.~9. Subjects allergic to any preparation components~10. Subjects who, in the opinion of the Investigator, should not be included in the study for any reason, including inability to follow study procedures.~11. Subjects who have participated in an investigational surgical, drug, or device study within the past 30 days.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Polyethylene glycol 3350 based bowel preparation (Type: ACTIVE_COMPARATOR): Polyethylene glycol 3350 based bowel preparation
- BLI800 (Type: EXPERIMENTAL): BLI800

Based on this trial design, predict the completion outcome and termination type (if applicable).